NEWS

News

December

Philogen announced Option and License Agreement with Pfizer Inc. to develop and commercialize multiple antibody drug conjugates and targeted nano particles. (see full press release). Siena (Italy), December 22nd, 2014.

Dario Neri - presented 'Immunocytokines for the therapy of cancer and of chronic inflammation' at Antibody Engineering and Therapeutics conference. Huntingdon Beach, California (USA), December 7th-11th, 2014.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.

I Accept Cookie Policy
X